Briefing Pfizer to acquire Trillium Therapeutics in US$2.26B deal https://thelogic.co/briefing/pfizer-to-acquire-trillium-therapeutics-in-us2-26b-deal/ By Aleksandra Sagan | Aug 23, 2021
Briefing Amplitude Venture Capital launches $200-million biotech fund focused on Canadian firms https://thelogic.co/briefing/amplitude-venture-capital-launches-200-million-biotech-fund-focused-on-canadian-firms/ By Zane Schwartz | Nov 6, 2019
Briefing Montreal cancer-treatment maker plans to raise at least US$100 million and list on the Nasdaq https://thelogic.co/briefing/montreal-cancer-treatment-maker-plans-to-raise-at-least-us100-million-and-list-on-the-nasdaq/ By Zane Schwartz | May 29, 2020
Briefing Kidney-drug developer Chinook Therapeutics listing on the Nasdaq https://thelogic.co/briefing/kidney-drug-developer-chinook-therapeutics-listing-on-the-nasdaq/ By Zane Schwartz | Jun 3, 2020
Briefing AbCellera raises IPO target https://thelogic.co/briefing/abcellera-raises-ipo-target/ By Aleksandra Sagan | Dec 7, 2020
Briefing Fusion files US$100-million IPO on the Nasdaq exchange https://thelogic.co/briefing/fusion-files-us100-million-ipo-on-the-nasdaq-exchange/ By Fatima Syed | Jun 8, 2020
Briefing Repare Therapeutics more than doubles IPO to US$230 million https://thelogic.co/briefing/repare-therapeutics-more-than-doubles-ipo-to-us230-million/ By Zane Schwartz | Jun 18, 2020
Briefing Vancouver’s Notch Therapeutics raises US$85 million as biotech rush continues https://thelogic.co/briefing/vancouvers-notch-therapeutics-raises-us85-million-as-biotech-rush-continues/ By Aleksandra Sagan | Feb 10, 2021
Briefing Quebec biotech sector sees $150-million investment https://thelogic.co/briefing/quebec-biotech-sector-sees-150-million-investment/ By Martin Patriquin | Jun 5, 2020
Briefing Montreal’s Clementia Pharmaceuticals accepts US$1-billion takeover bid https://thelogic.co/briefing/montreals-clementia-pharmaceuticals-accepts-us1-billion-takeover-bid/ By Zane Schwartz | Feb 26, 2019